In patients with proliferative diabetic retinopathy, treatment with anti–vascular endothelial growth factor may offer a safer alternative to panretinal photocoagulation , leading to fewer complications and a reduced need for additional surgeries.Researchers performed a retrospective cohort study to compare the outcomes of PRP and anti-VEGF monotherapy in patients with proliferative diabetic retinopathy from January 2003 to September 2023.
The risk for undergoing vitrectomy was higher in patients who received laser treatment alone at 1 (risk difference , 0.86%;"These findings suggest that PDR treated with PRP monotherapy had an increased relative risk to develop complications of PDR compared with matched patients treated with anti-VEGF monotherapy, although confounding factors could account for some of the associations," the authors wrote.Amer F.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: MSNBC - 🏆 469. / 51 Read more »